NACDS Applauds DEA Ruling on EPCS

June 24, 2011
The National Association of Chain Drug Stores (NACDS) has publically applauded the Drug Enforcement Administration (DEA) for issuing its interim

The National Association of Chain Drug Stores (NACDS) has publically applauded the Drug Enforcement Administration (DEA) for issuing its interim final rule allowing for the electronic prescribing of controlled substances (EPCS), permitting for the first time a coordinated e-prescribing system for both controlled and non-controlled prescription medication.

Previously, physicians frequently reported the inability to utilize EPCS as one of the main barriers preventing the widespread adoption of e-prescribing.

NACDS had been campaigning for EPCS for a decade, working with the DEA, the Department of Health and Human Services, pharmacy partners, intermediaries such as Surescripts, and technology vendors. Implementation of the ruling will take six months or more, allowing time for stakeholders to comply.

Today, most pharmacies in the United States have the capability to receive electronic prescriptions, and the number of prescriptions routed electronically grew from 68 million in 2008 to 191 million in 2009.

Sponsored Recommendations

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...

A 4-step plan for denial prevention

Denial prevention is a top priority in today’s revenue cycle. It’s also one area where most organizations fall behind. The good news? The technology and tactics to prevent denials...

Healthcare Industry Predictions 2024 and Beyond

The next five years are all about mastering generative AI — is the healthcare industry ready?